← Evidence map

ArticleJAMA2023

Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?

Jennifer J Manly et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37459138